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Blood transfusion is and will remain a life-saving
therapeutic option for many diseases. However, zero risk
of transfusion still remains a dream to be fulfilled. The
major risks of blood transfusion include transfusion
transmitted infections (TTI) and adverse transfusion
reactions.1 With sensitive screening tests for infectious
diseases and introduction of pathogen inactivation
methods, the risk of TTI has greatly reduced. However, the
worldwide problem now is the risk of wrong transfusion.2
Wrong transfusions have plagued transfusion practice in
the last century and still remain unresolved. Wrong
transfusion is a broad term. The term wrong transfusion
encompasses all cases where wrong ABO/Rh blood group
unit is administered leading to serious haemolytic
reaction or when a wrong type of blood component is
transfused, for instance, red cells instead of plasma.
According to Serious Hazards of transfusion (SHOT)
cumulative data from 1996-2013, incorrect blood
component transfused (IBCT) remains the most common
transfusion related adverse event.3 IBCT is an avoidable
mistake but it had remained unchanged over years
despite multiple interventions including education,
training and guidelines. It must also be noted that if
transfusion of blood components is not justified and the
patient is unnecessarily exposed to the risks of blood
therapy, it would be classified as wrong transfusion.
Safety in transfusion medicine is important because
patient's life is at stake and it must be the top priority of
health care professionals. So the question is that how can
we minimize, if not completely eliminate, wrong
transfusions.
First of all, reporting of transfusion reactions is essential as
it leads to identification of root causes. This would enable
the organizations to take corrective and preventive
actions andminimize future occurrence of similar events.4
The role of hospital transfusion committees in this respect
cannot be emphasized more. Each hospital should have
an active and functioning transfusion committee with
members from all clinical departments, nursing
department and blood bank. The committee shall be
responsible for collecting haemovigilance data and
analyzing root causes of all wrong transfusions. Repeated
education of all personnel involved in transfusion process
is another way to promote transfusion safety. This can be
done by conducting CMEs, arranging workshops and
lectures for physicians and nurses and circulating
educational flyers on regular basis.
Recently, advances in information technology (IT) have
tremendously improved transfusion safety. Using IT
technology in blood bank minimizes human errors.5 For
example, introduction of electronic patient identification
system using barcoding technology reduces errors
related to patient identification. A study has reported
significant improvements in transfusion safety using end
to end electronic control in transfusion process.6 With
respect to transfusion safety, a slight breech in patient
identification can lead to dire consequences including
death. Most of mismatched transfusions results from
failure to correctly identify the intended recipient.
Administration of blood/blood component thus remains
a major point of weakness in the transfusion chain.
Proper attention must be paid to correctly identify the
patient at time of blood administration.
Some of the European countries started Bedside ABO
grouping to minimize the incidence of wrong
transfusions. Bedside ABO grouping is used as a final
check to verify patient's blood group before transfusion. A
study from France reported that linking bedside ABO
grouping with another patient's identity check raises the
sensitivity of the whole bedside identification procedure
to 99.65% for detection of ABO incompatibilities.7 This
linkage ensures that the right blood is given to the right
patient. This was initiated by French regulation in 2003
and incidence of ABO incompatible transfusions have
declined much faster in France than in any other country
and the French haemovigilance system reports the lowest
rate of ABO incompatible transfusions. Bedside ABO
grouping has also been adopted by one of the leading
hospitals of Pakistan.
In addition to patient misidentification errors, some cases
of wrong transfusion are attributed to errors at
transfusion laboratory level. This could be due to errors in
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performing and interpreting blood group or transcription
errors. In some cases there is wrong release of blood from
blood bank. To reduce errors in blood bank, the best
solution in today's world is automation in blood bank. It is
reported that there is an exponential error reduction in
pre transfusion testing with automation.8 Automation
reduces human intervention by automatically performing
the blood group and transmitting results into lab
information system.
To facilitate physicians in judiciously ordering
blood/blood components and aid in decision making,
computer physician order entry systems (CPOE) have
been designed. The system helps physicians make
appropriate requests and avoid unnecessary transfusions.
CPOE has been in place for pharmacy for many years and
has shown to reduce serious medication incidents by
55%.9 The same findings may be applicable to blood
transfusion.
To conclude, most of the errors leading to wrong
transfusion are avoidable. It is time for us to adopt the
latest technologies available worldwide to improve
transfusion safety in our country.
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